Fig 1From: Renal function in β-thalassemia major patients treated with two different iron-chelation regimes– Patients included in previous study and in the present study according to treatment group. (DFX) Deferasirox. (DFO) Desferrioxamine. (DFP) Deferiprone. (*) Patients included in the previous study [6]. (**) Patients included in previous study and in present studyBack to article page